← Back to Search

THRIVE Intervention for Transition Care (THRIVE-SMI Trial)

N/A
Waitlist Available
Led By Jacqueline M Brooks Carthon, PhD,RN
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medicaid insured
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 months
Awards & highlights

THRIVE-SMI Trial Summary

This trial is evaluating a clinical pathway called THRIVE at HUP-Cedar. The pathway aims to support Medicaid-insured individuals, including those with serious mental illness, after they leave the hospital. The

Who is the study for?
This trial is for adults with Medicaid insurance in Pennsylvania who have been hospitalized and agree to home care. It's designed to help those, especially with serious mental illness, transition after hospitalization.Check my eligibility
What is being tested?
The THRIVE clinical pathway is being tested. It includes a home care nurse visit within 48 hours of discharge and ongoing care coordination for 30 days, aiming to reduce readmissions and emergency visits compared to standard care.See study design
What are the potential side effects?
Since this study focuses on a service intervention rather than medication, traditional side effects are not applicable. However, there may be potential challenges or issues related to the implementation of the new care pathway.

THRIVE-SMI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am covered by Medicaid.

THRIVE-SMI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Care or Specialist Visit
Rates of Emergency Department Visit
Rates of Readmissions
+1 more
Secondary outcome measures
Feasibility, Acceptability, Appropriateness, Workload

THRIVE-SMI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: THRIVE InterventionExperimental Treatment1 Intervention
THRIVE Intervention 1-month intensive post discharge case management and care coordination
Group II: Usual CareActive Control1 Intervention
Discharge to home without intensive post-acute case management or care coordination.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,009 Previous Clinical Trials
42,894,386 Total Patients Enrolled
3 Trials studying Transition Care
13,206 Patients Enrolled for Transition Care
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,816,904 Total Patients Enrolled
2 Trials studying Transition Care
5,960 Patients Enrolled for Transition Care
Jacqueline M Brooks Carthon, PhD,RNPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to enroll in this ongoing clinical trial?

"Based on the information provided by clinicaltrials.gov, it appears that this particular study is not currently seeking participants. The trial was initially posted on March 30, 2024 and was last updated on January 2, 2024. However, there are presently 371 other ongoing clinical trials actively recruiting individuals at this time."

Answered by AI
~178 spots leftby Feb 2026